Archive
BioNeutra Board Changes
![]() | |||||||||
![]() | |||||||||
Vancouver, British Columbia – (October 17, 2025) – TheNewswire - BioNeutra Global Corporation (“BioNeutra” or the “Company”) (TSXV: BGA; OTC Pink: BGACF) announces that Mr. Bill Smith has resigned as Chairman of the Board, as a Board Director, as a member of the Audit Committee, and as Special Advisor to the CEO of BioNeutra Global Corporation effective August 14, 2025. Mr. Smith’s resignation has been accepted by the Board..
Mr. Robin Le Fevre has become the Board Chairman effective October 9 of 2025.
Dr. Jianhua Zhu, the Chief Executive Officer and Director of the Company, states; “Mr. Bill Smith has served in the Board and Company of BioNeutra for many years, and has made many valuable contributions to the Board and Company of BioNeutra and we thank him for his contributions, commitment and dedication.”
About BioNeutra
BioNeutra is an award-winning, sector-leading Canadian company in the business of research and development, production and commercialization of ingredients for nutraceutical, functional and mainstream foods and beverages with a focus on its lead product - VitaFiber® IMO.
VitaFiber® IMO is made using a patented process that naturally transforms starch molecules from agricultural crops such as pea or tapioca into healthy, functional molecules. The VitaFiber manufacturing process is based upon a natural enzymatic conversion of the molecules without any chemical modification involved making VitaFiber® IMO a natural food and beverage ingredient. VitaFiber® IMO is also non-GMO, vegan friendly, gluten-free, Kosher and Halal certified and available as certified organic.
VitaFiber® IMO has been approved for sale by the world’s top three health regulatory bodies – GRAS approved by the US Food & Drug Administration; the European Food Safety Authority and Health Canada (approved as a novel food ingredient and dietary fiber). VitaFiber® IMO is a naturally sweet, low calorie alternative to sugar and is a natural source of dietary fiber and prebiotics for human digestive health. It is also helpful with weight management.
The Company’s customers include a mix of small and medium businesses as well as a number of high-profile food and beverage manufacturers on four continents.
Further information about BioNeutra is available on the Company’s website at www.bioneutra.ca and the SEDAR website at www.sedar.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information on BioNeutra, please contact:
Dr. Jianhua Zhu
President and Chief Executive Officer
Email: jianhua.zhu@bioneutra.ca

